Ibrexafungerp Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

SCY-078 (Ibrexafungerp) is an oral and intravenous antifungal drug.

Indications

Ibrexafungerp is approved for the treatment of vaginal candidiasis (VVC) in adults and children women who have experienced their first menstrual period.

Ibrexafungerp Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Ibrexafungerp Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Taizhou Creating Bio-pharm co., ltd.	0576-88827176; +8613586099526	post@creatingbiopharm.com	China	224	58
Shaanxi Didu New Materials Co. Ltd	+86-86-17392712697 +8617792793228	1069@dideu.com	China	8662	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19936	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32467	58
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1026@dideu.com	China	28509	58
TargetMol Chemicals Inc.	+1-781-999-5354;	support@targetmol.com	United States	39040	58
SUZHOU SENFEIDA CHEMICAL CO.,LTD	+86-0512-83500002 +8618662433356	3899766280@qq.com	China	26362	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8467	58
Soochow Chirally Material Science and Technology Co.,Ltd	+86-51266834346 +86-17751128648	sales@krl-tech.com	China	1050	58
Nantong Hi-Future Biotechnology Co., Ltd	18051384581	sales@chemhifuture.com	China	2988	58

---

• MK 3118
• 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-
• Ibrexafungerp (SCY-078)
• ibrexafungerp
• Ibrexafungerp(MK-3118)，SCY-078
• Ibrexafungerp(MK-3118)
• Brexafemme
• MK-3118
• SCY-078
• 1207753-03-4
• 1699043-15-1
• C44H67N5O4